Arena Pharmaceuticals, Inc.
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 10 name spellings.
43
Ending by 2030
May 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 2, 2026The maintenance fee for Processes for the preparation of 5-HT2C receptor agonists (US 9,045,431) comes due Dec 2, 2026. Unpaid by Jun 2, 2027, it lapses early.
- 2 fees due Jan 16 to 21, 2027 · next Jan 16
- 2 fees due Feb 18 to 27, 2027 · next Feb 18
- 3 fees due Mar 5 to 8, 2027 · next Mar 5
- 2 fees due Apr 3 to 27, 2027 · next Apr 3
- 5 fees due May 3 to 28, 2027 · next May 3
- 3 fees due Jul 21 to 30, 2027 · next Jul 21
- 2 fees due Aug 2 to 13, 2027 · next Aug 2
- 1 fee due Sep 10, 2027The maintenance fee for Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto (US 10,583,122) comes due Sep 10, 2027. Unpaid by Mar 10, 2028, it lapses early.
- 2 fees due Oct 21 to 28, 2027 · next Oct 21
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,664,258 | Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto In force · From the USPTO record | In force | From the USPTO record | |
| US 8,680,119 | Ethers, Secondary Amines and Derivatives Thereof as Modulators of the 5-HT2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto In force · Medium confidence | In force | Medium confidence | |
| US 9,199,940 | Crystalline Forms and Processes for the Preparation of Phenyl-Pyrazoles Useful as Modulators of the 5-HT2A Serotonin Receptor In force · High confidence | In force | High confidence | |
| US 9,221,755 | Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto In force · From the USPTO record | In force | From the USPTO record | |
| US 9,783,502 | Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT2A serotonin receptor In force · From the USPTO record | In force | From the USPTO record | |
| US 9,987,252 | Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto In force · From the USPTO record | In force | From the USPTO record | |
| US 10,450,276 | Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto In force · From the USPTO record | In force | From the USPTO record | |
| US RE45,336 | Primary Amines and Derivatives Thereof as Modulators of the 5-HT2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto In force · Low confidence | In force | Low confidence | |
| US RE45,337 | Ethers, Secondary Amines and Derivatives Thereof as Modulators of the 5-HT 2A Serotonin Receptor Useful for the Treatment of Disorders Related Thereto In force · Low confidence | In force | Low confidence | |
| US 9,732,039 | Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 113: 2 patents in force now held by others · 70 lapsed for an unpaid fee · 34 ended at full term · 4 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
13 pending · 12 abandoned · 121 no status recorded